These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8436117)

  • 21. Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation.
    Attur MG; Dave MN; Leung MY; Cipolletta C; Meseck M; Woo SL; Amin AR
    J Immunol; 2002 Feb; 168(4):2001-10. PubMed ID: 11823537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of site-specific mutations on biologic activities of recombinant human IL-6.
    Snouwaert JN; Kariya K; Fowlkes DM
    J Immunol; 1991 Jan; 146(2):585-91. PubMed ID: 1987278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Permuteins of interleukin 1 beta--a simplified approach for the construction of permutated proteins having new termini.
    Horlick RA; George HJ; Cooke GM; Tritch RJ; Newton RC; Dwivedi A; Lischwe M; Salemme FR; Weber PC; Horuk R
    Protein Eng; 1992 Jul; 5(5):427-31. PubMed ID: 1518791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rabbit IL-1. Cloning, expression, biologic properties, and transcription during endotoxemia.
    Cannon JG; Clark BD; Wingfield P; Schmeissner U; Losberger C; Dinarello CA; Shaw AR
    J Immunol; 1989 Apr; 142(7):2299-306. PubMed ID: 2784458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modularity of protein function: chimeric interleukin 1 beta s containing specific protease inhibitor loops retain function of both molecules.
    Wolfson AJ; Kanaoka M; Lau F; Ringe D; Young P; Lee J; Blumenthal J
    Biochemistry; 1993 May; 32(20):5327-31. PubMed ID: 8499437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential modulation of degradative and repair responses of interleukin-1-treated chondrocytes by platelet-derived growth factor.
    Harvey AK; Stack ST; Chandrasekhar S
    Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):129-36. PubMed ID: 8503839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1beta epitope mapping using site-directed mutagenesis and hydrogen-deuterium exchange mass spectrometry analysis.
    Lu J; Witcher DR; White MA; Wang X; Huang L; Rathnachalam R; Beals JM; Kuhstoss S
    Biochemistry; 2005 Aug; 44(33):11106-14. PubMed ID: 16101294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An antibody to a 17 amino acid synthetic peptide of the type I interleukin-1 receptor preferentially blocks interleukin-1 beta binding.
    Clark BD; Ikejima T; Mancilla J; Orencole SF; Sirko SP; Ishii N; Okuda K; Dinarello CA
    J Interferon Cytokine Res; 1996 Dec; 16(12):1079-88. PubMed ID: 8974012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 beta.
    Huang JJ; Newton RC; Pezzella K; Covington M; Tamblyn T; Rutlege SJ; Gray J; Kelley M; Lin Y
    Mol Biol Med; 1987 Jun; 4(3):169-81. PubMed ID: 3306264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation.
    Ollivierre F; Gubler U; Towle CA; Laurencin C; Treadwell BV
    Biochem Biophys Res Commun; 1986 Dec; 141(3):904-11. PubMed ID: 3028392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function analysis of human IL-1 alpha: identification of residues required for binding to the human type I IL-1 receptor.
    Labriola-Tompkins E; Chandran C; Varnell TA; Madison VS; Ju G
    Protein Eng; 1993 Jul; 6(5):535-9. PubMed ID: 7692435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of critical regions within the TIR domain of IL-1 receptor type I.
    Radons J; Falk W; Dove S
    Int J Biochem Cell Biol; 2015 Nov; 68():15-20. PubMed ID: 26279140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion body formation and protein stability in sequence variants of interleukin-1 beta.
    Chrunyk BA; Evans J; Lillquist J; Young P; Wetzel R
    J Biol Chem; 1993 Aug; 268(24):18053-61. PubMed ID: 8394358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of leucine residues in the C-terminal region of human interleukin-6 in the biological activity.
    Nishimura C; Ekida T; Nomura K; Sakamoto K; Suzuki H; Yasukawa K; Kishimoto T; Arata Y
    FEBS Lett; 1992 Oct; 311(3):271-5. PubMed ID: 1327882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cartilage degradation and suppression of PGE
    Akhtar N; Khan NM; Ashruf OS; Haqqi TM
    Nutrition; 2017 Jan; 33():1-13. PubMed ID: 27908544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.
    Kilian PL; Kaffka KL; Stern AS; Woehle D; Benjamin WR; Dechiara TM; Gubler U; Farrar JJ; Mizel SB; Lomedico PT
    J Immunol; 1986 Jun; 136(12):4509-14. PubMed ID: 2940296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
    Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M
    J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures.
    Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP
    Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. I. Functional characterization by monoclonal antibodies.
    MacDonald HR; Lees RK; Bron C
    J Immunol; 1985 Dec; 135(6):3944-50. PubMed ID: 2415592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.